← Browse by Condition
Medical Condition
hematologic neoplasms
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2
NCT05882175
Recruiting
Prospective Validation of the OHI Index
Enrollment
300 pts
Location
Israel
Sponsor
Meir Medical Center
NCT03735992
Recruiting
Mind-body Medicine for Patients With Malignant Hematological Diseases
Enrollment
94 pts
Location
Germany
Sponsor
Universität Duisburg-Essen
NCT05327023 Phase 1, Phase 2
Recruiting
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
Enrollment
430 pts
Location
United States
Sponsor
National Cancer Institute (NCI...